COMMUNIQUÉS West-GlobeNewswire

Sol-Gel Technologies Announces Participation in Upcoming Investor Conference
29/11/2018
NESS ZIONA, Israel, Nov. 29, 2018 (GLOBE NEWSWIRE) -- Sol-Gel Technologies Ltd. (NASDAQ: SLGL) (“Sol-Gel” or the “Company”), a clinical-stage dermatology company focused on identifying, developing and commercializing [...]
ChemoCentryx’s Novel Small Molecule Antagonists of Checkpoint Inhibitors and Chemokine Receptors to be Presented at the American Association for Cancer Research (AACR) Tumor Immunology and Immunotherapy Conference
29/11/2018
-- Studies highlight CCX4503, a unique small molecule inhibitor of immune checkpoint molecules PD-1/PD-L1, demonstrates anti-tumor efficacy in vivo -- -- Company’s studies also show CCR4 inhibition enhances [...]
Principia Biopharma Reports Positive PRN1008 Phase 2 Top-Line Results and Initiates Phase 3 Pemphigus Program
29/11/2018
- Achieved Phase 2 primary endpoint – over 50% of patients attained Control of Disease Activity within four weeks of starting PRN1008 - - Demonstrated sustained clinical efficacy at 12 weeks of therapy, a secondary [...]
SI-BONE, Inc. Reports Third Quarter 2018 Financial Results
29/11/2018
SANTA CLARA, Calif., Nov. 29, 2018 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq:SIBN), a medical device company that pioneered the minimally invasive surgical treatment of the sacroiliac joint with the iFuse Implant System [...]
Atara Biotherapeutics Highlights Next-Generation and Off-the-Shelf, Allogeneic CAR T Technologies and Pipeline
29/11/2018
Atara has assembled core technologies and capabilities to develop next-generation and off-the-shelf, allogeneic CAR T immunotherapies, collaborating with academic leaders as well as leveraging the Company’s world-class [...]
Molecular You Receives Innovation Award for Advancing Personalized Health Through its Biomarker Health Assessments
29/11/2018
VANCOUVER, British Columbia, Nov. 29, 2018 (GLOBE NEWSWIRE) -- Molecular You is proud to announce it is a 2018 recipient of a TEC Edmonton Spin-Off Achievement Award for the commercialization of personalized health [...]
CORRECTING and REPLACING -- US FDA approves Invivoscribe LeukoStrat CDx FLT3 Mutation Assay as CDx and Astellas drug XOSPATA (gilteritinib fumarate) for treatment of AML patients in the US
29/11/2018
Invivoscribe also Receives National Reimbursement for CDx Assay in Japan SAN DIEGO, Nov. 29, 2018 (GLOBE NEWSWIRE) -- In a release issued under the same headline earlier today by Invivoscribe, Inc., please note the [...]
EssilorLuxottica - Press Release: EssilorLuxottica 2018 Combined Shareholders' Meeting
29/11/2018
EssilorLuxottica 2018 Combined Shareholders' Meeting Charenton-Le-Pont (November 29, 2018 - 8:00 pm) - EssilorLuxottica held its first Combined General Meeting today at the Espace Grande Arche at La Défense, chaired by [...]
EssilorLuxottica - Communiqué : Assemblée Générale Mixte EssilorLuxottica 2018
29/11/2018
Assemblée Générale Mixte EssilorLuxottica 2018 Charenton-le-Pont (29 novembre 2018 - 20:00) - EssilorLuxottica a tenu aujourd'hui sa première Assemblée Générale Mixte à l'Espace Grande Arche à La Défense, présidée par [...]
Constellation Pharmaceuticals to Present at BMO Healthcare Conference
29/11/2018
CAMBRIDGE, Mass., Nov. 29, 2018 (GLOBE NEWSWIRE) -- Constellation Pharmaceuticals , Inc. (Nasdaq: CNST), a clinical-stage biopharmaceutical company using its expertise in epigenetics to discover and develop novel [...]
Resolutions passed at the annual general meeting of Chr. Hansen Holding A/S
29/11/2018
Company Announcement No. 24/2018 November 29, 2018 For further information please contact: Martin Riise, Senior Director, Investor Relations, Tel: +45 5339 2250 Camilla Lercke, Head of Media Relations, Tel: +45 5339 [...]
Tauriga Sciences Inc. to Proceed in Development and Launch of Cannabis Infused Chewing Gum Product Line
29/11/2018
New York, NY, Nov. 29, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Tauriga Sciences, Inc. ( TAUG ) (“Tauriga” or the “Company”), engaged in building its business through the development, distribution, and licensing of [...]
Canopy Growth Completes Strategic Extract Supply Agreement with MediPharm Labs
29/11/2018
SMITHS FALLS & BARRIE, Ontario, Nov. 29, 2018 (GLOBE NEWSWIRE) -- Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX:WEED, NYSE:CGC) and MediPharm Labs Inc. (“MediPharm”), a specialized cannabis [...]
PotNetwork Holdings, Inc.’s Diamond CBD Launches Program To Sell Its Products in Shopping Malls Across America on Black Friday at Broward Mall in South Florida
29/11/2018
New Program Focusing on Educating Consumers on the Benefits of Diamond CBD to Build Brand Preference FORT LAUDERDALE, Fla., Nov. 29, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- PotNetwork Holdings, Inc. (OTC Pink: POTN [...]
Canadian Tech Company B-Temia Enters Into a $6.9M USD US Army / Lockheed Martin Agreement
29/11/2018
B-Temia and Lockheed Martin Team Up to Optimize ONYX™ Exoskeleton QUÉBEC CITY, Nov. 29, 2018 (GLOBE NEWSWIRE) -- B-Temia, a Canadian robotics tech company and leader in the human mobility market, announced its [...]
B-Temia, une société canadienne de technologie conclut une entente de 6,9 millions $ US avec l’armée américaine / Lockheed Martin
29/11/2018
B-Temia et Lockheed Martin font équipe en vue d’optimiser l’exosquelette ONYX™ QUÉBEC, 29 nov. 2018 (GLOBE NEWSWIRE) -- B-Temia, une société de technologie robotique canadienne à la tête du marché de la mobilité humaine [...]
Constellation Pharmaceuticals Appoints Patrick Trojer, Ph.D., as Chief Scientific Officer
29/11/2018
CAMBRIDGE, Mass., Nov. 29, 2018 (GLOBE NEWSWIRE) -- Constellation Pharmaceuticals , Inc. (the “Company”) (Nasdaq: CNST), a clinical-stage biopharmaceutical company using its expertise in epigenetics to discover and [...]
Rafael Pharmaceuticals Announces Initiation of Pivotal Phase 3 Trial (ARMADA 2000) of CPI-613 (devimistat) in Patients with Relapsed or Refractory Acute Myeloid Leukemia (AML)
29/11/2018
500 patients will be evaluated in this study at approximately 87 sites in 12 countries. The interim analysis is expected to be completed as early as Q1 2020. Newark, NJ, Nov. 29, 2018 (GLOBE NEWSWIRE) -- Rafael [...]
On “Grindeks” results in the first nine months of 2018
29/11/2018
Turnover of “Grindeks” reaches 102.4 million euro in the first nine months of 2018; profit – 7.6 million euro Today, on 29 November, the JSC “Grindeks” submitted the non-audited consolidated financial statements for the [...]

Pages